Jan 24, 2023

Kim Wirthlin to Lead Huntsman Cancer Foundation as President and COO

Generous donations make the remarkable growth and advancements in cancer care at Huntsman Cancer Institute possible. Huntsman Cancer Foundation, the nonprofit organization whose sole purpose is to raise funds to support the institute, has a new leader. Kim Wirthlin will be the president and chief operating officer (COO) beginning February 1. The foundation’s work is critical in supporting cutting-edge research and the highest standards of clinical care at Huntsman Cancer Institute.

Jan 18, 2023

Daniel Ermann, MD, Selected as Scholar for the 2023 Lymphoma Scientific Research Mentoring Program

Daniel Ermann, MD, has been selected for the highly competitive Lymphoma Scientific Research Mentoring Program, class of 2023. This program awards a career development grant of $10,000 to the selected scholars, which will help Ermann fund his research. His award-winning clinical trial investigates the effectiveness of current pneumonia vaccine practices recommended for people with chronic lymphoma, and whether these could be improved upon to reduce infections and death for these patients.

Jan 05, 2023

Proud to Be One of the Best: 2022 WebMD ‘Elite Award’ Given to Huntsman Cancer Institute

WebMD grants Huntsman Cancer Institute the Elite Award in oncology. The Elite Award recognizes health systems that are preferred two to one over competitors. This award, and many others, continue to show the community’s trust in Huntsman Cancer Institute’s cancer care and treatment.

Nov 17, 2022

Researchers, Providers, and Programs Recognized with National Cancer Community (C2) Awards

Huntsman Cancer Institute’s Doug Fair, MD, and Center for HOPE team earned 2022 Cancer Community (C2) awards for their outstanding work and contributions to cancer research and patient care. Former Huntsman Cancer Institute researcher Charles Rogers, PhD, was also honored with an award. Alana Welm, PhD, and Kathi Mooney, PhD, RN were also featured as award finalists.

Nov 14, 2022

Moderate Exercise Helps Colorectal Cancer Patients Live Longer by Reducing Inflammation and Improving Gut Bacteria, including in Patients Who Are Obese

A brisk walk for 20 minutes a day may not sound like much, but it could make a big difference for colorectal cancer patients. Regular physical activity reduces inflammation by improving the gut microbiome of patients, including patients who are obese, scientists at Huntsman Cancer Institute found. They researched the impact of exercise on the gut microbiome, the trillions of bacteria that live in our digestive system. Investigators found moderate exercise improved outcomes in colorectal cancer, the third most common cancer in the United States, excluding skin cancers. Scientists explain why their findings are so significant.

Nov 11, 2022

Huntsman Cancer Institute Designated as First Clinical Research Center of Excellence

Pheochromocytoma or paraganglioma are rare neuroendocrine tumors that can be hereditary and passed down to children. Due to its outstanding work providing high-quality treatment, care, education, and clinical trials to patients, Huntsman Cancer Institute has been designated as the first Clinical and Research Center of Excellence by the Pheo Para Alliance, an organization working to raise awareness.

Nov 09, 2022

New Vice President Named At Huntsman Cancer Foundation

Huntsman Cancer Foundation president and COO, Susan Sheehan, has promoted Loren Savage to vice president for the foundation. Savage began working for the foundation six years ago and has been recognized for his leadership through a succession of promotions. Throughout his tenure, he has contributed to increased donations leading to new facility construction and advancements in cancer research. Savage brings more than 23 years of experience in non-profit work to his new role with the foundation.

Nov 04, 2022

CDC Data Suggests Attitudes Are Shifting about the HPV Vaccine: Utah Vaccine Rates among Teens Increased more than 16%

Many more Utah teens are getting vaccinated for HPV, protecting them against six types of cancer. The state saw a significant increase in HPV vaccinations after a long history of mixed messages and misunderstandings about the vaccine. Huntsman Cancer Institute experts explain what’s working, and one woman tells about her harrowing cancer journey.